# Treatment of HYpertension: Morning Versus Evening

> **NCT02214498** · PHASE4 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Enalapril/hydrochlorothiazide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02214498
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02214498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02214498, "Treatment of HYpertension: Morning Versus Evening". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02214498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*